Artificial pancreatic perfusion device with temperature sensitive matrix
First Claim
1. An artificial pancreatic perfusion device for providing insulin to an individual, the device comprising:
- a) a hollow fiber having one end connected to a blood vessel through a connecting means to receive blood from the individual and an opposite end connected to a blood vessel through a second connecting means to return blood to the individual, the hollow fiber having a porosity which selectively allows substances to pass transversely therethrough, such that blood flows within the hollow fiber, along the length of the fiber; and
b) a housing containing a suspension of pancreatic islets of Langerhans, the suspension including pancreatic islets distributed in a temperature sensitive supporting material about the hollow fiber such that the hollow fiber is surrounded by pancreatic islets along its length, the supporting material characterized by (i) being sufficiently viscous at temperatures below about 45°
C. to maintain distribution of the islets with respect to the hollow fiber, and (ii) being sufficiently fluid at temperatures above about 45°
C. to enable removal of the islet suspension for subsequent replacement thereof.
4 Assignments
0 Petitions
Accused Products
Abstract
A device which serves as an artificial pancreas comprises a hollow fiber which is surrounded by islets of Langerhans enclosed in a housing. The islets are suspended in a temperature sensitive matrix which is sufficiently viscous to support islets at a temperature below about 45° C. and sufficiently fluid to enable removal of islet suspension at a temperature above about 45° C. A warm (e.g., 48° to 50° C.) solution may be flushed through the device to change the physical state of the temperature sensitive matrix from a semi-solid state to a liquified semi-gel state. The temperature sensitive supporting material also enables long term maintenance of islet cells in in vitro culture.
-
Citations
16 Claims
-
1. An artificial pancreatic perfusion device for providing insulin to an individual, the device comprising:
-
a) a hollow fiber having one end connected to a blood vessel through a connecting means to receive blood from the individual and an opposite end connected to a blood vessel through a second connecting means to return blood to the individual, the hollow fiber having a porosity which selectively allows substances to pass transversely therethrough, such that blood flows within the hollow fiber, along the length of the fiber; and b) a housing containing a suspension of pancreatic islets of Langerhans, the suspension including pancreatic islets distributed in a temperature sensitive supporting material about the hollow fiber such that the hollow fiber is surrounded by pancreatic islets along its length, the supporting material characterized by (i) being sufficiently viscous at temperatures below about 45°
C. to maintain distribution of the islets with respect to the hollow fiber, and (ii) being sufficiently fluid at temperatures above about 45°
C. to enable removal of the islet suspension for subsequent replacement thereof. - View Dependent Claims (2, 3, 4)
-
-
5. In an artificial pancreatic perfusion device for providing insulin to an individual, the device comprising (i) a hollow fiber with a porosity that selectively allows substances to pass transversely therethrough and (ii) a housing containing a suspension of pancreatic islets of Langerhans about the hollow fiber, the improvement comprising:
a temperature sensitive matrix in which the islets are distributed and suspended to form a pipettable islet suspension, the matrix being sufficiently viscous at temperatures below about 45°
C. to physically suspend and maintain the islets positioned about the hollow fiber and sufficiently fluid at temperatures above about 45°
C. to enable removal of the islet suspension for subsequent replacement thereof.- View Dependent Claims (6, 7)
-
8. A method for seeding a device with islets of Langerhans on multiple occasions before and after use of the device for the production of insulin, comprising the steps of:
-
(a) forming an islet suspension by distributing the islets in a temperature sensitive supporting material sufficiently viscous at temperatures below about 45°
C. to physically suspend the islets and sufficiently fluid at temperatures above about 45°
C. to enable removal of the islet suspension from the device as desired;(b) introducing a first portion of islet suspension into the device, such first portion sufficient for the production of a desired amount of insulin by the device, wherein such first portion is in a semi-gel state; (c) cooling to form a semi-solid matrix; (d) subsequently warming to convert the semi-solid matrix to a semi-gel; (e) withdrawing some or all of said first portion of islet suspension from the device; and (f) introducing a second portion of islet suspension into the device, such second portion sufficient for the production of a desired amount of insulin by the device, wherein such second portion is in a semi-gel state. - View Dependent Claims (9, 10, 11, 12)
-
-
13. A method of preparing islets of Langerhans for use in a device, comprising the steps of:
-
(a) providing islets; (b) combining the islets with cell culture medium and a sufficient amount of a supporting material to form an islet mixture, the supporting material being sufficiently viscous at temperatures below about 45°
C. to maintain suspension of the islets and sufficiently fluid at temperatures above about 45°
C. to enable removal of the inlet suspension from the device; and(c) storing the islet mixture under in vitro culture conditions suitable for maintaining islets; and (d) forming a pipettable islet suspension phase from an amount of the islet mixture, by removing the cell culture medium from the islet mixture. - View Dependent Claims (14, 15)
-
-
16. A method of preparing islets of Langerhans for use in a device, comprising the steps of:
-
(a) providing islets; (b) combining the islets with cell culture medium and a sufficient amount of a supporting material to form an islet mixture, the supporting material being sufficiently viscous at temperatures below about 45°
C. to maintain suspension of the islets and sufficiently fluid at temperatures above about 45°
C. to enable removal of the islet suspension from the device;(c) storing the islet mixture under in vitro culture conditions suitable for maintaining islets; (d) warming the islet mixture to at least about 45°
C.;(e) removing the islet mixture from in vitro culture; (f) centrifuging the islet mixture to form a culture medium phase and an islet suspension phase; and (g) isolating the islet suspension phase for use in the device.
-
Specification